PT1335938E - Construções de apolipoproteínas - Google Patents
Construções de apolipoproteínas Download PDFInfo
- Publication number
- PT1335938E PT1335938E PT01982197T PT01982197T PT1335938E PT 1335938 E PT1335938 E PT 1335938E PT 01982197 T PT01982197 T PT 01982197T PT 01982197 T PT01982197 T PT 01982197T PT 1335938 E PT1335938 E PT 1335938E
- Authority
- PT
- Portugal
- Prior art keywords
- leu
- glu
- lys
- gin
- ala
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/775—Apolipopeptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
- C07K2319/21—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/31—Fusion polypeptide fusions, other than Fc, for prolonged plasma life, e.g. albumin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/50—Fusion polypeptide containing protease site
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/73—Fusion polypeptide containing domain for protein-protein interaction containing coiled-coiled motif (leucine zippers)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Toxicology (AREA)
- Physics & Mathematics (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA200001682 | 2000-11-10 | ||
DKPA200100057 | 2001-01-15 | ||
US26402201P | 2001-01-26 | 2001-01-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
PT1335938E true PT1335938E (pt) | 2010-12-22 |
Family
ID=42813922
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT01982197T PT1335938E (pt) | 2000-11-10 | 2001-11-09 | Construções de apolipoproteínas |
Country Status (6)
Country | Link |
---|---|
KR (2) | KR101034901B1 (ko) |
AT (1) | ATE482232T1 (ko) |
DE (1) | DE60143122D1 (ko) |
DK (1) | DK1335938T3 (ko) |
PT (1) | PT1335938E (ko) |
SI (1) | SI1335938T1 (ko) |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6004925A (en) * | 1997-09-29 | 1999-12-21 | J. L. Dasseux | Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders |
-
2001
- 2001-11-09 KR KR1020037006365A patent/KR101034901B1/ko not_active IP Right Cessation
- 2001-11-09 DK DK01982197.4T patent/DK1335938T3/da active
- 2001-11-09 PT PT01982197T patent/PT1335938E/pt unknown
- 2001-11-09 KR KR1020117004844A patent/KR101172045B1/ko not_active IP Right Cessation
- 2001-11-09 SI SI200130984T patent/SI1335938T1/sl unknown
- 2001-11-09 DE DE60143122T patent/DE60143122D1/de not_active Expired - Lifetime
- 2001-11-09 AT AT01982197T patent/ATE482232T1/de active
Also Published As
Publication number | Publication date |
---|---|
DK1335938T3 (da) | 2010-12-13 |
KR101172045B1 (ko) | 2013-05-14 |
KR20110038160A (ko) | 2011-04-13 |
DE60143122D1 (de) | 2010-11-04 |
ATE482232T1 (de) | 2010-10-15 |
KR101034901B1 (ko) | 2011-05-17 |
KR20030048138A (ko) | 2003-06-18 |
SI1335938T1 (sl) | 2011-01-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002213843B2 (en) | Apolipoprotein analogues | |
AU2002213843A1 (en) | Apolipoprotein analogues | |
KR101993714B1 (ko) | 대사 장애를 치료하는데 이용하기 위한 조성물과 방법 | |
EA029685B1 (ru) | Комплекс фактора viii с xten и белком фактора фон виллебранда и его применение (варианты) | |
PT2621515T (pt) | Polipéptido quimérico de leptina de foca-ser humano com solubilidade aumentada | |
US20230036052A1 (en) | Modified protein | |
CZ68597A3 (en) | Modified human c3 proteins | |
CN107530407A (zh) | 丙酰辅酶a羧化酶组合物及其用途 | |
EP2004680B1 (en) | N-terminal vdac variants and uses thereof | |
AU2008201887B2 (en) | Apolipoprotein analogues | |
PT1335938E (pt) | Construções de apolipoproteínas | |
ES2356181T3 (es) | Construcción de apolipoproteínas. | |
US10385113B2 (en) | Engineered FGF compositions and methods of use thereof | |
TW434256B (en) | Antigen non-specific glycosylation inhibiting factor derivatives | |
KR20240029769A (ko) | 융합단백질 및 이의 응용 | |
Dhani | Experimental approaches for the structural characterization of membrane-spanning segments in proteins | |
Ahn | Structural Studies of the Saposins and PagP. | |
JP2001512010A (ja) | 膵線維症の遺伝子治療及びタンパク質治療用でグルタチオン−s−トランスフェラーゼ機能を誘発する製剤 |